Brain Tumor Pathology

, Volume 28, Issue 1, pp 33–42 | Cite as

Persistent roles of signal transduction of platelet-derived growth factor B in genesis, growth, and anaplastic transformation of gliomas in an in-vivo serial transplantation model

  • Rina Torisu
  • Satoshi O. SuzukiEmail author
  • Kenta Masui
  • Koji Yoshimoto
  • Masahiro Mizoguchi
  • Makoto Hashizume
  • Peter Canoll
  • James E. Goldman
  • Tomio Sasaki
  • Toru Iwaki
Original Article


We previously reported that retrovirally transduced platelet-derived growth factor-B (PDGFB) in glial progenitors of the rat cerebral white matter, subventricular zone, or brain stem induced malignant brain tumors closely resembling human glioblastoma (GBM). While human GBMs may progress over the period of several months to a few years, prospective, long-term in-vivo observation of histological changes of the tumor tissues is not feasible in these models, because the animals undergo rapid tumor progression and mortality within approximately 1 month. We thus performed successive, long-term in-vivo transplantation of the PDGFB-induced tumor cells into the rat cerebrum. Primary retroviral transduction of PDGFB in the glial progenitors of the rat basal ganglia induced malignant glioma resembling human GBM or anaplastic oligodendroglioma (AOL) consisting of relatively monomorphous tumor cells expressing markers for the oligodendrocyte lineage. In the course of long-term successive transplantation, tumor cells presented pleomorphism as well as focal GFAP expression. This suggests that secondary chromosomal aberration and dysregulation of gene expression following accelerated cell cycle by PDGFB stimulation would induce morphological and immunophenotypic changes in tumor cells. Furthermore, while the primary tumors contained only a minor fraction of proviral GFP-expressing or hemagglutinin-expressing cells, most tumor cells came to express these proviral genes in the course of serial transplantation suggesting a persistent role of PDGFB-expressing cells in maintenance and growth of the tumors. This model would be useful for investigation of the long-term effects of PDGFB stimulation in glioma tissues on anaplastic evolution.


Oligodendrocyte precursors PDGF Glioma Animal model Successive transplantation 



The authors would like to thank Dr Kensuke Sasaki for instruction in statistical analysis, Dr Yoshihiro Seki for helpful comments and supports, and Ms Sachiko Nagae and Kimiko Sato for their excellent technical instruction and assistance (all from Department of Neuropathology, Kyushu University). They also thank Dr Hideki Horikawa (Department of Neuropsychiatry, Kyushu University) for instruction of ELISA, and Dr Sumako Nishimura and Dr Takeshi Yasunaga (Hitachi Medical Corporation) for their excellent technical assistance with open-MRI.


  1. 1.
    Furnari FB, Fenton T, Bachoo RM et al (2007) Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21:2683–2710CrossRefPubMedGoogle Scholar
  2. 2.
    Louis DN, Holland EC, Cairncross JG (2001) Glioma classification: a molecular reappraisal. Am J Pathol 159:779–786CrossRefPubMedGoogle Scholar
  3. 3.
    Louis DN, Ohgaki H, Wiestler OD et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109CrossRefPubMedGoogle Scholar
  4. 4.
    Di Rocco F, Carroll RS, Zhang J et al (1998) Platelet-derived growth factor and its receptor expression in human oligodendrogliomas. Neurosurgery 42:341–346CrossRefPubMedGoogle Scholar
  5. 5.
    Nister M, Libermann TA, Betsholtz C et al (1988) Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines. Cancer Res 48:3910–3918PubMedGoogle Scholar
  6. 6.
    Hermanson M, Funa K, Hartman M et al (1992) Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 52:3213–3219PubMedGoogle Scholar
  7. 7.
    Armstrong RC, Harvath L, Dubois-Dalcq ME (1990) Type 1 astrocytes and oligodendrocyte-type 2 astrocyte glial progenitors migrate toward distinct molecules. J Neurosci Res 27:400–407CrossRefPubMedGoogle Scholar
  8. 8.
    Frost EE, Zhou Z, Krasnesky K et al (2008) Initiation of oligodendrocyte progenitor cell migration by a PDGF-A activated extracellular regulated kinase (ERK) signaling pathway. Neurochem Res 34:169–181CrossRefPubMedGoogle Scholar
  9. 9.
    Noble M, Murray K, Stroobant P et al (1988) Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature 333:560–562CrossRefPubMedGoogle Scholar
  10. 10.
    Bogler O, Wren D, Barnett SC et al (1990) Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells. Proc Natl Acad Sci USA 87:6368–6372CrossRefPubMedGoogle Scholar
  11. 11.
    McKinnon RD, Matsui T, Dubois-Dalcq M et al (1990) FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron 5:603–614CrossRefPubMedGoogle Scholar
  12. 12.
    Dai C, Celestino JC, Okada Y et al (2001) PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev 15:1913–1925CrossRefPubMedGoogle Scholar
  13. 13.
    Hesselager G, Uhrbom L, Westermark B et al (2003) Complementary effects of platelet-derived growth factor autocrine stimulation and p53 or Ink4a-Arf deletion in a mouse glioma model. Cancer Res 63:4305–4309PubMedGoogle Scholar
  14. 14.
    Uhrbom L, Hesselager G, Nister M et al (1998) Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus. Cancer Res 58:5275–5279PubMedGoogle Scholar
  15. 15.
    Appolloni I, Calzolari F, Tutucci E et al (2009) PDGF-B induces a homogeneous class of oligodendrogliomas from embryonic neural progenitors. Int J Cancer 124(10):2251–2259CrossRefPubMedGoogle Scholar
  16. 16.
    Calzolari F, Appolloni I, Tutucci E et al (2008) Tumor progression and oncogene addiction in a PDGF-B-induced model of gliomagenesis. Neoplasia 10:1373–1382PubMedGoogle Scholar
  17. 17.
    Assanah M, Lochhead R, Ogden A et al (2006) Glial progenitors in adult white matter are driven to form malignant gliomas by platelet-derived growth factor-expressing retroviruses. J Neurosci 26:6781–6790CrossRefPubMedGoogle Scholar
  18. 18.
    Jackson EL, Garcia-Verdugo JM, Gil-Perotin S et al (2006) PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling. Neuron 51:187–199CrossRefPubMedGoogle Scholar
  19. 19.
    Assanah MC, Bruce JN, Suzuki SO et al (2009) PDGF stimulates the massive expansion of glial progenitors in the neonatal forebrain. Glia 57(16):1835–1847CrossRefPubMedGoogle Scholar
  20. 20.
    Masui K, Suzuki SO, Torisu R et al (2010) Glial progenitors in the brainstem give rise to malignant gliomas by platelet-derived growth factor stimulation. Glia 58(9):1050–1065CrossRefPubMedGoogle Scholar
  21. 21.
    Gensert JM, Goldman JE (2001) Heterogeneity of cycling glial progenitors in the adult mammalian cortex and white matter. J Neurobiol 48:75–86CrossRefPubMedGoogle Scholar
  22. 22.
    Mason JL, Goldman JE (2002) A2B5+ and O4+ cycling progenitors in the adult forebrain white matter respond differentially to PDGF-AA, FGF-2, and IGF-1. Mol Cell Neurosci 20:30–42CrossRefPubMedGoogle Scholar
  23. 23.
    Fleming TP, Saxena A, Clark WC et al (1992) Amplification and/or overexpression of platelet derived growth factor receptors and epidermal growth factor receptor in human glial tumors. Cancer Res 52:4550–4553PubMedGoogle Scholar
  24. 24.
    Shih AH, Dai C, Hu X et al (2004) Dose-dependent effects of platelet derived growth factor-B on glial tumorigenesis. Cancer Res 64:4783–4789CrossRefPubMedGoogle Scholar
  25. 25.
    Majumdar K, Radotra BD, Vasishta RK et al (2009) Platelet-derived growth factor expression correlates with tumor grade and proliferative activity in human oligodendrogliomas. Surg Neurol 72:54–60CrossRefPubMedGoogle Scholar
  26. 26.
    Verhaak RGW, Hoadley KA, Purdom E et al (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17:98–110CrossRefPubMedGoogle Scholar
  27. 27.
    Uhrbom L, Nerio E, Holland EC (2004) Dissecting tumor maintenance requirements using bioluminescence imaging of cell proliferation in a mouse glioma model. Nat Med 10:1257–1260CrossRefPubMedGoogle Scholar

Copyright information

© The Japan Society of Brain Tumor Pathology 2010

Authors and Affiliations

  • Rina Torisu
    • 1
    • 2
  • Satoshi O. Suzuki
    • 1
    Email author
  • Kenta Masui
    • 1
  • Koji Yoshimoto
    • 2
  • Masahiro Mizoguchi
    • 2
  • Makoto Hashizume
    • 3
  • Peter Canoll
    • 4
  • James E. Goldman
    • 4
  • Tomio Sasaki
    • 2
  • Toru Iwaki
    • 1
  1. 1.Department of Neuropathology, Graduate School of Medical SciencesKyushu UniversityFukuokaJapan
  2. 2.Department of Neurosurgery, Graduate School of Medical SciencesKyushu UniversityFukuokaJapan
  3. 3.Department of Advanced Medical Initiatives, Graduate School of Medical SciencesKyushu UniversityFukuokaJapan
  4. 4.Department of PathologyColumbia University College of Physicians and SurgeonsNew YorkUSA

Personalised recommendations